Arkolith/Insider Trading/RARE/Form 4

Kassberg Thomas Richard

CBO & EVPUltragenyx Pharmaceutical Inc. (RARE) · full profile →Form 4 · filed Mar 4, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$254K
Net Open-Market Flow
-$254K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Tax withholding(F)508$42.92$22K265K
Mar 3, 2025Sell(S)6K$42.10$254K265K
Mar 1, 2025Grant(A)18K—$0271K

Transaction Codes

F
Shares withheld for taxes
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-032802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML